Senior Health Channel
Topics & Medications
Related Channels

Side Effects of Solifenacin Succinate

Blurry vision, dry mouth, constipation, and urinary tract infection are the most commonly reported side effects of solifenacin succinate. These side effects are usually mild and, in most cases, do not need to be reported to a healthcare provider. However, certain solifenacin succinate side effects are potentially serious and may require immediate medical attention, such as depression, confusion, and difficulty urinating.

An Introduction to Side Effects of Solifenacin Succinate

As with any medicine, side effects are possible with solifenacin succinate (VESIcare®); however, not everyone who takes the drug will experience side effects. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or can easily be treated by you or your healthcare provider.
(This article covers many, but not all, of the possible side effects with solifenacin succinate. Your healthcare provider can discuss a more complete list of solifenacin succinate side effects with you.)

Serious Side Effects of Solifenacin Succinate

Some side effects with solifenacin succinate, while occurring infrequently, are potentially serious and should be reported immediately to your healthcare provider. These include but are not limited to:
  • Severe constipation
  • Worsening of glaucoma
  • Difficulty passing urine
  • Confusion
  • Depression
  • Signs of an allergic reaction, such as unexplained rash, hives, itching, wheezing, and unexplained swelling.
The Dirty, Messy Part of BPH

Solifenacin for Overactive Bladder

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.